A double-blind, randomised controlled study was conducted to evaluate the intubation conditions in 20 preterm neonates following the use of either morphine or remifentanil as premedication. The findings suggest that the overall intubation conditions were significantly better (p = 0.0034) in the remifentanil group than in the morphine group. No severe complications were observed in either group. E ndotracheal intubation of preterm neonates forms a major part of routine practice in the neonatal intensive care unit (NICU). This procedure is associated with physiological and biochemical responses, and premedication (sedation and analgesia) seems to improve physiological stability and decrease the time taken for and the level of difficulty of the procedure.1 Morphine has been used for several years in most NICUs with apparent safety and efficacy, and midazolam is given for sedation. However, morphine has several limitations, the main one being its delayed onset of action, which makes the drug unsuitable for premedication.1 2 In this setting, remifentanil has theoretical and practical advantages over other sedative drugs, making it appropriate for noxious procedures such as intubation and ventilation. 4 The aim of our randomised double-blind study was to compare the intubation conditions achieved following sedation with remifentanil and morphine in preterm neonates with respiratory distress syndrome (RDS).
PATIENTS AND METHODSOur study population included 20 preterm neonates (28-34 weeks' gestation) admitted to a single tertiary NICU, who required elective tracheal intubation to treat respiratory failure due to RDS. The ethics committee of our institution approved the study, and informed consent was obtained from parents of all selected neonates. Neonates were excluded from the study if they had major congenital malformations, birth weight less than 1000 g, previous or concurrent use of opioids or haemodynamic instability before intubation.Following enrolment the neonates were randomised sequentially, using a random numbers table, to receive an intravenous bolus injection over 1 min of either morphine 150 mg/kg and midazolam 200 mg/kg or remifentanil 1 mg/kg and midazolam 200 mg/kg. A single pharmacist was responsible for allocating each neonate in the randomised treatment group, and she also ensured that the two preparations could not be differentiated.The neonates were preoxygenated with 100% oxygen and a monitor (Dixtal 2010; Dixtal Collaborative Evolution, São Paulo, Brazil) recorded the heart rate, blood pressure and oxygen saturation (SaO 2 ). A single paediatric anaesthetist, who was blinded to the study protocol, carried out all intubations and classified the intubation conditions as poor, good or excellent. 5 The intubation conditions were scored using a four-point scale and the variables assessed were: ease of laryngoscopy, position of the vocal cords, coughing, jaw relaxation and movement of the limbs.
5The blood pressure, heart rate and SpO 2 were recorded before and during the first 10 min after the intub...